Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Recovering from budget neglect requires a clear plan: rebuild essential budgets, tackle debt strategically, and track progress weekly.
28,655 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Federal OSHA has opened a federal review of Nevada’s workplace safety agency after three willful citations against El...
Iran has quietly formalized yuan-based fees for ships passing the Strait of Hormuz as U.S. forces position nearby. Th...
Perella Weinberg stock lags the broader market, even as a major fund just boosted its stake by about $15 million. Thi...
A teen who left school to work on his dad’s site rose to a six-figure construction business by 22. The story mirrors ...
Honda Motor Co. announced a nationwide recall covering about 880,000 vehicles due to a suspected rear suspension prob...
Private credit funds are tightening access to withdrawals through redemption limits. This article explains the mechan...
Blue Origin plans a $10 billion round at a $130 billion valuation, backed by Jeff Bezos and institutional investors. ...
New market analysis shows that a $10,000 investment in JPMorgan when Jamie Dimon took over would be worth six figures...
A Tuesday surge in Uber stock sparked curiosity among investors. This article dives into the catalysts, profitability...
Investors woke up to a modest rally in Intel as executives highlighted strong demand and expansion plans. This articl...
Can bloom energy stock going to $200 actually happen? This guide breaks down the catalysts, risks, and practical stra...